Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Belluscura PLC on Wednesday announced it received purchase orders for over 6,500 of its DISCOV-R portable oxygen concentrator.
Belluscura shares jumped 17% to 43.34 pence each on Wednesday morning in London.
The medical device developer focused on lightweight and portable oxygen enrichment technology said the order meant potential revenue of $15 million as it expects production of the concentrator to start by the end of this quarter.
Further, Belluscura said it is progressing with its registration mark applications for the EU’s product safety CE mark and the UK’s product safety UKCA mark for its X-PLOR portable oxygen concentrator.
Chief Executive Officer Bob Rauker said: ‘This marks another exciting development for the company, delivering on our strategy to design and manufacture highly differentiated, high quality and high margin products. Amid growing sales and continued progress with our X-PLOR device and Nomad app, we continue to seek further opportunities to improve the quality of life for our end users’.
The company plans a continued roll out of its DISCOV-R concentrator in autumn and into 2024.
Copyright 2023 Alliance News Ltd. All Rights Reserved.